Advanced Search

    column
    Exploring the Depths and Tackling the Challenges: Clinical Advances in the Diagnosis and Treatment of Thymic Epithelial Tumors
    FU Xiao-shuang, HAO Yue, SONG Zheng-bo
    2025, 25(5): 253-260. DOI: 10.12019/j.issn.1671-5144.202511031
    Abstract PDF
    Illuminating the Clinical Role of Avelumab Plus Axitinib in Unresectable or Metastatic Type B3 Thymomas and Thymic Carcinomas
    HAO Yue, LI Zi-ming
    2025, 25(5): 261-266. DOI: 10.12019/j.issn.1671-5144.202510030
    Abstract PDF
    Palbociclib Monotherapy for Recurrent or Refractory Advanced Thymic Epithelial Tumors: Review of KCSG LU17-21 Study
    PAN Lu-yun, LV Tang-feng
    2025, 25(5): 267-271. DOI: 10.12019/j.issn.1671-5144.202508008
    Abstract PDF
    In-Depth Analysis of the STYLE Trial: Defining the Therapeutic Boundaries and Clinical Role of Sunitinib as Second-Line Treatment for Type B3 Thymoma and Thymic Carcinoma
    CHEN Cheng-yu, WANG Qian
    2025, 25(5): 272-275. DOI: 10.12019/j.issn.1671-5144.202511019
    Abstract PDF
    Blazing New Trails: The Application of Apatinib in Recurrent or Metastatic Thymic Epithelial Tumors
    WANG Ke, XU Chun-wei
    2025, 25(5): 276-279. DOI: 10.12019/j.issn.1671-5144.202510029
    Abstract PDF
    Lenatinib in the Treatment of Thymic Carcinoma After Prior Platinum-Based Chemotherapy Failure: Insights From the Prospective Phase Ⅱ REMORA Study
    LAN Hong-wei, ZHANG Qi, ZHANG Yu
    2025, 25(5): 280-283. DOI: 10.12019/j.issn.1671-5144.202511024
    Abstract PDF
    Pembrolizumab for the Treatment of Refractory or Relapsed Thymic Epithelial Tumors: Review of the NCT02607631 Study
    YOU Shuang, MENG Rui
    2025, 25(5): 284-289. DOI: 10.12019/j.issn.1671-5144.202508016
    Abstract PDF
    Everolimus Monotherapy for Advanced or Recurrent Advanced Thymic Epithelial Tumors Progressing After Platinum-Based Chemotherapy: Review of NCT02049047 Study
    ZHANG Yu-qi, GAO Wen
    2025, 25(5): 290-296. DOI: 10.12019/j.issn.1671-5144.202508009
    Abstract PDF
    A Comparative Study on the Application Effects of MDT-ERAS and Conventional ERAS in the Perioperative Period of Robotic Pancreaticoduodenectomy
    WANG Ai-mei, XIONG Dai-lan, DING Yan-ling, DAI Lin-lin, DENG Yan-ying
    2025, 25(5): 297-303. DOI: 10.12019/j.issn.1671-5144.202506003
    Abstract PDF
    Clinical Characteristics and Efficacy of EGFR-TKIs in Advanced NSCLC Patients Harboring the Rare EGFR Compound Mutation L833V/H835L
    SUN Yue-li, PENG Ying-long, YANG Jin-ji, TU Hai-yan
    2025, 25(5): 304-313. DOI: 10.12019/j.issn.1671-5144.202510023
    Abstract PDF
    Successful Downstaging and Surgical Resection With Neoadjuvant Immunotherapy Plus Chemotherapy in Stage ⅢB Potentially Resectable Non-Small Cell Lung Cancer: A Case Discussion
    CONG Yun-yan, HUANG Bing-jiang, ZHONG Hong-cheng, WANG Zhi-hui
    2025, 25(5): 314-320. DOI: 10.12019/j.issn.1671-5144.202507042
    Abstract PDF